Related Experiment Video
Updated: Apr 29, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
In vivo imaging as a pharmacodynamic marker
Astrid A M van der Veldt1, Adriaan A Lammertsma2
1Authors' Affiliations: Departments of Internal Medicine, Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the NetherlandsAuthors' Affiliations: Departments of Internal Medicine, Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands aam.vanderveldt@vumc.nl.
Positron emission tomography (PET) with radiolabeled anticancer drugs like paclitaxel and docetaxel helps understand drug behavior. This approach aids in personalized cancer treatment planning and developing new radiolabeled therapies.
Area of Science:
- Nuclear Medicine
- Radiopharmacology
- Oncology
Background:
- Anticancer drug clinical behavior (pharmacokinetics, biodistribution, toxicity, efficacy) requires further understanding.
- Positron emission tomography (PET) using radiolabeled drugs offers a promising method for in-vivo drug evaluation.
- Taxanes are a class of anticancer drugs with established experience in radiolabeling for PET imaging.
Purpose of the Study:
- To review data on radiolabeled taxanes, specifically [(18)F]paclitaxel and [(11)C]docetaxel, as PET tracers.
- To link PET imaging data with clinical observations from paclitaxel and docetaxel therapy.
- To discuss the current applications and future potential of PET in evaluating radiolabeled anticancer drugs.
Main Methods:
- Review of existing literature on [(18)F]paclitaxel and [(11)C]docetaxel.
- Correlation of PET imaging findings with clinical outcomes of taxane-based chemotherapy.
- Discussion of the broader implications for developing other radiolabeled anticancer agents.
Main Results:
- [(18)F]paclitaxel and [(11)C]docetaxel are established PET tracers for evaluating taxane behavior.
- PET imaging provides insights into pharmacokinetics, biodistribution, and potentially efficacy of these agents.
- Clinical data supports the utility of these radiolabeled taxanes in understanding drug action.
Conclusions:
- Radiolabeled taxanes like [(18)F]paclitaxel and [(11)C]docetaxel are valuable tools in oncology research.
- PET imaging with radiolabeled drugs can enhance understanding of anticancer agent behavior and guide treatment.
- Experience with taxanes can inform the development of novel radiolabeled drugs for various cancers.
Related Concept Videos
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Measurement of Bioavailability: Pharmacodynamic Methods

